Your Strength. Our Knowledge and Experience.

The most critical warning sign of skin cancer is the appearance of a new spot on the skin or changes in an existing spot that seem abnormal. Following the A B C D E guidelines can help you identify the common signs of skin cancer:

• Asymmetry:One half of a mole (or birthmark) does not match the other half.
• Border:Edges are irregular, ragged, notched, or blurred.
• Color:The color is uneven, often featuring different shades of brown or black, along with patches of pink, red, white, or blue.
• Diameter:The spot is larger than 6 millimeters across (about the size of a pencil eraser).
• Evolving:The mole is changing in size, shape, color, or elevation. 

Skin cancer is typically identified first by a healthcare professional during an examination of an unusual area on the skin. However, determining whether it is cancerous requires removal and subsequent testing, known as a biopsy. This is the only reliable method to confirm a skin cancer diagnosis.

You may have your biopsy performed in a dermatologist’s office or as an outpatient procedure in a hospital or clinic, depending on the size and location of the abnormal area. Local anesthesia is usually administered to ensure your comfort.

There are four common types of skin biopsies:

• Punch Biopsy:A sharp, hollow tool is used to remove a circle of tissue from the abnormal area.
• Incisional Biopsy:A scalpel is employed to remove a portion of the growth.
• Excisional Biopsy:The entire growth and some surrounding tissue are removed with a scalpel.
• Shave Biopsy:A thin, sharp blade is used to shave off the abnormal growth.

If there is a possibility of melanoma, dermatologists will generally avoid simply shaving or cauterizing the growth. Instead, an excisional biopsy will be performed, or if the growth is too large, a tissue sample will be collected.

Upon receiving a biopsy confirmation of skin cancer, you will be referred to a specialized oncologist for further evaluation and care. Understanding the extent, or stage, of your cancer is crucial, whether you have melanoma or nonmelanoma skin cancer. Staging involves a meticulous assessment to determine how thick the tumor is and whether it has metastasized to other parts of the body. If the tumor is particularly thick, your doctor may recommend chest x-rays, blood tests, and imaging scans of the liver, bones, and brain.

Knowing the stage of your cancer enables your oncologist to:

• Assess the seriousness of your cancer and your chances for survival
• Formulate the most effective treatment plan for your unique situation
• Identify clinical trials that may present additional treatment options

In some cases, your oncologist may need to examine your lymph nodes to accurately stage the cancer. Surgical procedures may be part of the treatment plan to remove cancerous lymph nodes, which can aid in managing the disease.

Staging Criteria
Staging is based on several key factors:

• The size of the tumor
• How deeply it has penetrated below the surface of the skin
• Whether it has spread to nearby lymph nodes or other organs

Oncologists utilize Roman numerals I through IV to designate the cancer stage. Stage I indicates small tumors that are confined to their original site, while Stage IV signifies advanced cancer that has spread to distant sites in the body.

Nonmelanoma Skin Cancer Staging
The stages of nonmelanoma skin cancer are as follows:

• Stage 0: The cancer is localized to the top layer of skin, classified as carcinoma in situ.
• Stage I: The tumor measures 2 centimeters (approximately three-quarters of an inch) or smaller.
• Stage II: The tumor exceeds 2 centimeters in diameter.
• Stage III: The cancer has spread beyond the skin to underlying tissues such as cartilage, muscle, or bone, or to nearby lymph nodes, but not to distant locations.
• Stage IV: The cancer has metastasized to other areas in the body.

Melanoma Staging
The staging for melanoma specifically is defined as follows:

• Stage 0: Melanoma cells are confined to the outer layer of skin (epidermis) and have not invaded deeper tissues.
• Stage I: In Stage I, the melanoma is considered thin:
  • The tumor is no thicker than 1 millimeter (1/25 inch) and may show signs of ulceration (a scraped appearance).
  • Alternatively, the tumor measures between 1 and 2 millimeters thick without ulceration, and melanoma cells have not spread to nearby lymph nodes.
• Stage II: At this stage, the tumor is at least 1 millimeter thick:
  • It may be between 1 and 2 millimeters thick and present with ulceration.
  • Alternatively, the tumor may be greater than 2 millimeters thick, potentially with ulceration, but has not yet spread to nearby lymph nodes.
• Stage III: This indicates that melanoma has spread to nearby lymph nodes or to tissues just outside the original tumor without affecting the lymph nodes.
• Stage IV: At this advanced stage, melanoma cells have metastasized to other organs, lymph nodes, or distant skin areas.
• Recurrent: Recurrent disease indicates that cancer has returned after treatment, either in the original site or in a new location within the body.

There are various approaches to treating skin cancer, and your oncologist will work closely with you to determine the most effective combination of therapies based on the stage of cancer and your overall health. We at El Portal Comprehensive Cancer Centers are dedicated to providing you with comprehensive care tailored to your needs, ensuring you receive the support, guidance, and treatment necessary for your journey toward recovery.

Nonmelanoma Skin Cancer Treatments

In some cases, the entire nonmelanoma skin cancer may be removed during the biopsy, which means no further treatment is necessary. However, if additional treatment is required, your doctor will outline the available options.

There are six primary types of nonmelanoma skin cancer treatments, which may be used individually or in combination:

1. Surgery
2. Chemotherapy
3. Photodynamic therapy
4. Radiation therapy
5. Biologic therapy
6. Targeted therapy

Melanoma Skin Cancer Treatments

Melanoma treatment encompasses nearly all the same options as nonmelanoma skin cancer, with the exception of photodynamic therapy.

Skin Cancer Treatment Options

Your oncologist can provide detailed explanations of the following surgical techniques:

• Wide-Local Excision (WLE): This common approach involves numbing the area and surgically removing the cancer along with a margin of surrounding healthy skin. The margin is examined microscopically to ensure all cancer cells have been excised, and the required margin size will depend on the tumor’s dimensions. In some cases, nearby lymph nodes may also be removed.
• Mohs Surgery: This technique is particularly beneficial for skin cancer treatment. The surgeon numbs the area and removes thin layers of the tumor, examining each layer under a microscope for cancer cells. The process continues until no cancerous cells are detected, ensuring complete tumor removal while preserving as much healthy tissue as possible.
• Electrodesiccation and Curettage: This method is ideal for small basal cell skin cancers. The doctor numbs the area, removes the cancer using a curette (a spoon-shaped surgical instrument), and then employs an electric current to control bleeding and eliminate any remaining cancer cells. This procedure tends to be quick and straightforward.
• Cryosurgery: This option is suitable for patients who may not tolerate other surgical methods. Cryosurgery employs extreme cold, typically generated from liquid nitrogen, to treat early-stage or very thin skin cancer lesions. While effective, this approach may cause swelling and could damage nerves in the area, leading to temporary loss of sensation.
• Laser Surgery: This technique involves using a focused beam of light to target and destroy cancer cells. It is primarily utilized for superficial growths confined to the outer layer of skin.
• Skin Grafting: Occasionally, grafts are necessary to cover openings left by surgical removal. In this procedure, the surgeon numbs the area and removes a patch of healthy skin from another part of your body, such as the thigh, to cover the excised area. It is important to provide special care to the graft site during the healing process.
• Lymphadenectomy: This surgical procedure may be employed in the case of melanoma, wherein lymph nodes are removed for evaluation. The removed tissue is examined under a microscope for cancer cells.
• Sentinel Lymph Node Biopsy: During this procedure, the sentinel lymph node—the first node likely to receive cancer spread from the tumor—is surgically removed. A radioactive substance and/or blue dye is injected near the tumor site to track the flow to the lymph nodes. If no cancer cells are found in the sentinel node, additional nodes may not need to be excised, making this a useful technique within melanoma treatment plans.

AUTHORIZATION REQUIRED: 

• Alignment Health Plan    
• AllCare IPA Merced (HMO/NO DERM)  
• ALLIANCE (CCAH)
• Anthem MediCAL Managed Care Prog.  
• Brand New Day-Universal Care, Inc.- Medicare 
• Calviva Health 
• Community Care IPA
• California Forensic Medical Group, Inc  
• Health Plan of San Joaquin HMO
• Kova Healthcare, Inc. IPA  
• Imperial Health Medical
• MediCAL  
• Central Valley Medical Providers IPA
• Sequoia Health IPA 
• United Healthcare (AARP)
• Sante Community Physicians  
• Tricare TriWest Healthare
• Alliance  
• Western Growers Assurance Trust  
• Central Valley Pace County Medical Services Program 
• Esperanza IPA- Medicare HMO
• Choice Program
• HealthNet CA- First Health Hill Physicians 
• Humana LaSalle Network Management IPA  
• Meritage Medical Network
• Seven Corners 

NO AUTHORIZATION REQUIRED: 

• Aetna
• Anthem
• Blue Cross of CA  
• Blue Shield of CA
• Medicare 
• UMR ACPN Network-America’s Choice PN  
• First Health Network-Cofinity Galaxy Health Network
• HealthSmart 
• CIGNA
• Anthem ACA Plans- Pathway EPO, PPO 
• BS of CA Promise Health Plan
• Medicare
• Railroad Multiplan/PHCS  
• NaphCare NX Health Network LLC d/b/a Valenz Access 
• Provider Network of America (PNOA)
• Wellcare
• WelbeHealth 

• Verify benefits, plan limits, referral, and pre-authorization requirements before your appointment.
• Bring your insurance card(s).
• Notify us of any insurance or personal information changes immediately.
• Understand your financial responsibility for co-pays, deductibles, and non-covered services.

• We verify and review your benefits.
• We help obtain necessary referrals and authorizations.
• We provide cost estimates.
• We inform you about financial assistance options.
• We bill your primary and, if authorized, secondary insurance.
• For Medicare patients, supervising physician info will be included on your claims.
• Our Financial Counselors can provide resources for you to help navigate obtaining traditional insurance coverage 

• Present your current insurance card at each visit.
• Keep us updated on insurance info.
• Pay co-pays at the time of service.
• Cover any balances remaining after insurance payments.

Receiving a prostate cancer diagnosis can be overwhelming, and there are important decisions to be made. It’s natural to have questions, and we are here to help you navigate your options and understand what lies ahead. You’ll learn about your cancer care team and what to expect as you embark on this journey.

What Type of Doctor Should You See First After a Prostate Cancer Diagnosis?

Typically, a urologist will perform the biopsy that confirms the presence of prostate cancer and assesses its aggressiveness. Following this initial diagnosis, we recommend scheduling a consultation with an oncologist. Our dedicated oncologists are well-versed in the latest treatment options, ensuring you receive therapies tailored specifically for you.

Your oncologist will help you understand the growth pattern of the cancer and how it may evolve moving forward. The biopsy results, combined with other diagnostic tests, will provide the necessary information to determine both the stage and grade of your prostate cancer.

Staging Prostate Cancer

Using the results from your biopsy and additional diagnostic tests, your oncologist will ascertain the stage of your prostate cancer. Further imaging or scans may be required to identify whether cancer cells have extended beyond the prostate.

Gleason Score and Grading

The Gleason score, included in your biopsy report, indicates how much the cancer cells have altered in various parts of the prostate. This grading aids in determining whether immediate treatment is necessary.

The Gleason score is a system used to grade prostate cancer based on how aggressive and likely it is to spread. It is determined by examining cancer cells under a microscope and assigning them a score from 1 to 5.

Grading:
1-2: Well-differentiated, least aggressive
3-4: Moderately differentiated
5: Poorly differentiated, most aggressive

Gleason scores are subject to interpretation and may vary slightly between pathologists. It is important to discuss your Gleason score with your healthcare provider to understand its implications and treatment options.

Preparing for Your First Oncology Appointment

Your first oncology appointment is essential for gathering important information, but it can be overwhelming. We suggest bringing a notebook or using your smartphone to take notes during the appointment. This will help you keep track of important details and any questions that arise.

We strongly encourage you to bring a friend or loved one for support. They can take notes, ask questions that might be on your mind, and provide reassurance.

Additionally, please bring your health records, including any prostate cancer test results, recent imaging scans, your insurance card, and a list of medications or supplements you’re currently taking.

Questions to Discuss with Your Oncologist

• How soon do I need to decide on a treatment plan?
• If “watchful waiting” is recommended, how often should I return for follow-up testing?
• What treatment options do you suggest when the time comes to proceed?
• What should I expect during future appointments?
• Are there lifestyle changes (in diet, exercise, rest, or stress management) I should consider?
• How should I manage any symptoms affecting my daily life?
• Are there any activities I should avoid or incorporate into my routine?
• Can I take nutritional supplements or vitamins to support my prostate health?
• Should my family and I consider genetic testing to check for hereditary risk?
• What supportive care resources are available through your practice or community organizations?

Feeling confident about your prostate cancer diagnosis and treatment plan is vital, even if it begins with watchful waiting. Many patients choose to seek a second opinion, and our oncologists are completely supportive of this decision. Insurance coverage for second opinions is often available, so we recommend contacting your insurance provider to verify your benefits before scheduling an appointment.

You Are Not Alone on Your Prostate Cancer Journey

At El Portal Comprehensive Cancer Centers, we are committed to supporting you throughout your entire journey. With convenient locations across Central California, we are here to offer you compassionate care and guidance every step of the way. Together, we will navigate this path to achieve the best possible outcome for your health and well-being.

Even after beating cancer, returning to work can feel overwhelming. You might wonder whether your ability to perform has changed or if colleagues will treat you differently. Preparing ahead of time by assessing your energy levels, discussing accommodations, and setting a manageable schedule can make the process smoother. Consider starting part-time or remote work if possible, and communicate openly with your supervisor about your needs. Remember, it’s okay to take things slow—your recovery and comfort come first.

Talking with Coworkers
Deciding what to share about your cancer journey is personal. You may choose to keep details private or share only with close colleagues. If you do decide to disclose, explaining your absence as due to treatment can foster understanding and support. Be honest about what you’re comfortable sharing, and set boundaries if questions become too personal. Most coworkers will respect your privacy and support your needs once they understand your situation. Remember, you control your story—only share what feels right for you.

Laws like the Americans with Disabilities Act provide protections against discrimination and require reasonable accommodations, such as flexible schedules or workplace modifications. You are entitled to support and fair treatment, and it’s important to understand these rights. If needed, the Family and Medical Leave Act offers job protection for up to 12 weeks of leave for illness-related reasons. If you face discrimination or unfair treatment, consulting legal resources or an employment lawyer can help you understand your options.

Infusions are used to treat a wide range of medical conditions, including:

• Cancer: Chemotherapy agents, targeted therapies, and immunotherapies are often administered via infusion to treat various cancers such as breast, lung, and leukemia.
• Autoimmune Disorders: Conditions like rheumatoid arthritis, lupus, and multiple sclerosis may be treated with biological agents delivered through infusions to help regulate the immune system.
• Infections: Severe infections might require antibiotics delivered through infusion for immediate and effective treatment.
• Nutritional Support: Patients unable to eat or absorb nutrients through the gastrointestinal tract may receive nutritional solutions (Total Parenteral Nutrition, TPN) via infusion.
• Pain Management: For chronic pain conditions, infusions of medications such as opioids or analgesics may provide relief.
• Hydration and Electrolyte Replacement: IV fluids are commonly used for rehydration in patients with severe dehydration or electrolyte imbalances.

While infusion therapy is generally safe, certain factors may increase the risk of complications, including:

• Allergies:Some patients may have allergic reactions to medications being infused.
• Infection Risk:The insertion of IV lines can lead to infections if not performed under sterile conditions.
• Pre-existing Conditions:Patients with compromised immune systems, heart conditions, or kidney issues may face additional risks.
• Substance Interactions:Patients should disclose all medications, supplements, and herbal products they are taking, as interactions can occur.

Timing of Treatments: The timing of infusion treatments varies based on the condition being treated:

• Cancer Patients: Infusion schedules can be based on specific chemotherapy regimens, often occurring every few weeks or as prescribed by an oncologist.
• Autoimmune Disorders: Infusions may be scheduled monthly or as part of a broader treatment plan based on symptoms and disease activity.
• Acute Conditions: Infusions for infections or severe hydration may occur as needed, often in a hospital setting.

Side effects of infusion therapy can vary depending on the type of medication and individual patient factors. Common side effects include:

• Infusion Reactions:Fever, chills, or rashes occurring during or shortly after the infusion.
• Nausea and Vomiting:Particularly common with chemotherapy agents.
• Fatigue:Many patients experience tiredness following infusion sessions.
• Infections:Risks associated with the use of IV lines.
• Local Reactions: Bruising, swelling, or inflammation at the injection site.

The success rate of infusion therapy depends on several factors, including:

• Type of Condition: Certain cancer treatments administered via infusion can have high cure rates, especially when applied at early stages.
• Individual Response: How a patient responds to the specific medication influences effectiveness.
• Comprehensive Treatment Plan: Optimizing infusion therapy as part of a broader treatment strategy (including surgery, radiotherapy, etc.) can enhance success rates.

For example:

• Chemotherapy: May lead to significant tumor shrinkage or remission in many cancer patients.
• Biologics for Autoimmunity: Often result in substantial improvements in symptoms and quality of life for patients with autoimmune diseases.

Hodgkin lymphoma (HL) can present with various signs and symptoms, which may evolve over time. Common symptoms include:

1. Swollen Lymph Nodes: The most prominent sign is usually painless swelling of lymph nodes in the neck, armpit, or groin. These nodes may feel firm or rubbery.
2. Fever: Patients may experience persistent fevers without an infectious cause, often referred to as “B symptoms.”
3. Night Sweats: Drenching night sweats that can soak clothing and bedding, often severe and uncomfortable.
4. Unexplained Weight Loss: Significant weight loss (more than 10% of body weight) over a short period without changes in diet or exercise.
5. Fatigue: Persistent fatigue or lack of energy that does not improve with rest.
6. Itching: Generalized itching (pruritus) can occur without a rash and may be bothersome.
7. Chest Pain or Cough: If the lymphoma affects areas in the chest, individuals may experience chest pain, persistent cough, or difficulty breathing.
8. Abdominal Pain or Swelling: Involvement of the abdomen may lead to pain or a sense of fullness due to enlarged lymph nodes or spleen.
9. Alcohol-Induced Pain: Some patients report pain in lymph nodes after consuming alcohol, which is quite specific to Hodgkin lymphoma.

Several factors can increase the risk of developing Hodgkin lymphoma:

1. Age: Hodgkin lymphoma is most commonly diagnosed in young adults aged 15-35 and older adults aged 55 and above.
2. Gender: It is more common in males than females.
3. Family History: A family history of Hodgkin lymphoma or other related cancers may increase risk.
4. Weakened Immune System: Individuals with weakened immune systems, such as those with HIV/AIDS or those on immunosuppressive therapy, have an increased risk.
5. Viral Infections: Infections with the Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV) are associated with an elevated risk.
6. Geographic Location: There are geographic variations in HL incidence, with higher rates reported in certain regions.
7. Obesity: Some studies suggest a potential link between obesity and an increased risk of Hodgkin lymphoma.
8. Previous Radiation Therapy: Individuals who received radiation therapy for other cancers, especially during childhood, may have a heightened risk.

The treatment of Hodgkin lymphoma (HL) often depends on the stage of the disease, tumor characteristics, the patient’s age, and overall health. Common treatment options include:

1. Chemotherapy: Chemotherapy is the cornerstone of treatment for Hodgkin lymphoma. Common regimens include ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine), which is effective in most patients.
2. Radiation Therapy: Radiation therapy may be used alone or in combination with chemotherapy, especially for localized disease (early-stage HL). It targets specific areas affected by lymphoma.
3. Stem Cell Transplant: For patients with relapsed or refractory Hodgkin lymphoma, high-dose chemotherapy followed by autologous stem cell transplantation may be considered. This allows for the use of higher doses of chemotherapy to effectively destroy cancer cells.
4. Immunotherapy: Newer targeted therapies, including monoclonal antibodies (like brentuximab vedotin), use the body’s immune system to fight cancer. This option may be used in certain cases of relapsed or refractory HL.
5. Clinical Trials: Participation in clinical trials may provide access to innovative therapies and new treatment approaches that are not yet widely available.
6. Supportive Care: Management of side effects and supportive care to maintain quality of life during treatment are crucial. This may include medication for nausea, pain management, and counseling services.

1. Hodgkin Lymphoma: The overall 5-year survival rate for Hodgkin lymphoma is approximately 87%, with a significant number of patients achieving long-term remission. Cure rates in early-stage HL can be even higher, exceeding 90%with appropriate treatment.
2. Advancements in Treatment: Cutting-edge treatments such as targeted therapies and immunotherapy (including CAR T-cell therapy) have shown promising results. In certain cases of relapsed/refractory NHL, CAR T-cell therapy has achieved response rates surpassing 50%.
3. Chemotherapy Success: First-line chemotherapy regimens for Hodgkin and many types of non-Hodgkin lymphoma, such as R-CHOP (rituximab combined with chemotherapy), lead to high initial response rates, with many patients showing significant reduction or complete disappearance of tumors.
4. Survivorship: Many lymphoma survivors go on to lead healthy, fulfilling lives. Long-term follow-up studies show that most individuals achieve a normal or near-normal quality of life after treatment, especially with supportive care and monitoring.

Treatment Modalities

• Combination Chemotherapy: Most lymphomas are treated with combination chemotherapy, which enhances the effectiveness of treatment and reduces the risk of resistance. Such regimens have improved overall survival rates for various lymphoma types.
• Radiation Therapy: For localized lymphoma, radiation therapy can be highly effective. It often leads to excellent outcomes, especially in early-stage Hodgkin lymphoma, with success rates over 90%.
• Stem Cell Transplants: For patients with relapsed or refractory lymphoma, autologous stem cell transplants can offer a chance of long-term remission. Survival rates post-transplant can be around 50-60%, depending on various factors.

Ongoing Research and Future Prospects

Customized Treatment Approaches: Advances in genetics and molecular biology allow for more personalized treatment approaches, enabling physicians to tailor therapies based on individual patient characteristics and disease profiles.

Non-Hodgkin Lymphoma (NHL) can present with a variety of signs and symptoms, which may vary depending on the subtype of NHL and the areas of the body affected. Common signs and symptoms include:

1. Lymphadenopathy: Swollen lymph nodes, particularly in the neck, armpits, or groin. These may feel rubbery or firm and are often painless.
2. Fever: Persistent fevers without an obvious cause, sometimes with chills.
3. Unexplained Weight Loss: Significant weight loss (more than 10% of body weight) without trying or without an underlying reason.
4. Night Sweats: Drenching night sweats that may soak through clothing and bedding.
5. Fatigue: Chronic fatigue or weakness that doesn’t improve with rest.
6. Abdominal Pain or Swelling: Pain or discomfort in the abdomen, which may also be associated with a swollen abdomen due to enlarged lymph nodes or spleen.
7. Chest Pain: If lymphoma affects the chest area, it can cause chest pain, coughing, or difficulty breathing.
8. Itching: Generalized itching (pruritus) without a rash, which can be quite bothersome.
9. Skin Changes: In some cases, NHL can present with skin rashes, lesions, or lumps.

It’s important to note that these symptoms can be caused by other health conditions as well; experiencing one or more of these symptoms doesn’t necessarily mean an individual has NHL. However, if symptoms persist or worsen, it is advisable to consult a healthcare professional for further evaluation.

Several factors can increase the risk of developing Non Hodgkin lymphoma (NHL):

1. Age: The risk of NHL increases with age, with most cases diagnosed in adults aged 60 and older.
2. Gender: Men are more likely to develop NHL than women.
3. Weakened Immune System: Individuals with weakened immune systems, such as those with HIV/AIDS, have a higher risk of developing NHL. Immunosuppressive treatments (e.g., for organ transplant patients) also increase risk.
4. Autoimmune Diseases: Conditions such as rheumatoid arthritis, lupus, or Sjögren’s syndrome can increase the risk due to chronic inflammation and immune activation.
5. Infections: Certain viral infections, such as the Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), and human T-cell lymphotropic virus (HTLV), have been linked to an increased risk of developing certain types of NHL.
6. Chemical Exposure: Exposure to certain chemicals, particularly pesticides, herbicides, and solvents such as benzene, may be associated with a higher risk of NHL.
7. Family History: A family history of lymphoma or other blood cancers may increase an individual’s risk.
8. Geographic Location: Some studies suggest that living in certain geographic regions with higher pesticide use or specific environmental exposures may contribute to an increased risk.
9. Obesity: Some research indicates that obesity may be a risk factor for developing various types of lymphoma.
10. Previous Radiation Therapy: Individuals who have received radiation therapy for other cancers may have an increased risk of developing NHL later.

1. Chemotherapy:Chemotherapy is often the first-line treatment for many types of NHL. It involves the use of powerful drugs to kill cancer cells or inhibit their growth. Commonly used chemotherapy regimens include:
   • R-CHOP:A combination of rituximab (a monoclonal antibody) with cyclophosphamide, doxorubicin, vincristine, and prednisone.
   • CHOP:Similar to R-CHOP but does not include rituximab.
2. Targeted Therapy: Targeted therapies are designed to specifically attack cancer cells while minimizing damage to normal cells. Some examples include:
   • Rituximab (Rituxan):A monoclonal antibody targeting CD20-positive B-cell lymphomas.
   • Brentuximab Vedotin (Adcetris):A medication that combines an antibody with a chemotherapy drug, used for specific subtypes of NHL.
3. Immunotherapy: Immunotherapy utilizes the body’s immune system to combat cancer cells. It includes therapies such as:
4. CAR T-Cell Therapy:A groundbreaking treatment that involves modifying a patient’s own T-cells to target and destroy lymphoma cells, showing high effectiveness in certain types of aggressive NHL.
5. Nivolumab (Opdivo) and Pembrolizumab (Keytruda):Immune checkpoint inhibitors that help the immune system recognize and attack cancer cells.
6. Radiation Therapy: Radiation therapy may be used to target specific areas of lymphoma, especially for localized disease. It can be effective in combination with chemotherapy for certain patients.
7. Stem Cell Transplant: For patients with high-risk or relapsed NHL, stem cell transplantation (autologous or allogeneic) may be considered. This approach allows for the use of high-dose chemotherapy to treat the lymphoma, followed by transplanting healthy stem cells to restore the bone marrow.
8. Supportive Care: Throughout treatment, supportive care is essential to manage side effects and improve quality of life. This can include anti-nausea medications, pain management, nutritional support, and counseling services.
9. Observation (Watchful Waiting): In some cases of indolent or slow-growing NHL, especially in asymptomatic patients, a strategy of “watchful waiting” may be recommended, where treatment is delayed until symptoms arise or the disease progresses.

Conclusion

Non-Hodgkin Lymphoma comprises a diverse group of diseases, and treatment plans are personalized based on many factors, including the specific lymphoma subtype and the patient’s overall health. Early diagnosis and access to effective therapies greatly enhance treatment success rates. It’s essential for patients to discuss all available treatment options with their healthcare providers to determine the most appropriate approach for their individual situation.

1. Non Hodgkin Lymphoma:The 5-year survival rate for non-Hodgkin lymphoma varies widely based on the specific type and stage but is generally around 72%. For some aggressive subtypes, advances in treatment have improved survival rates markedly.
2. Advancements in Treatment: Cutting-edge treatments such as targeted therapies and immunotherapy (including CAR T-cell therapy) have shown promising results. In certain cases of relapsed/refractory NHL, CAR T-cell therapy has achieved response rates surpassing 50%.
3. Chemotherapy Success: First-line chemotherapy regimens for Hodgkin and many types of non-Hodgkin lymphoma, such as R-CHOP (rituximab combined with chemotherapy), lead to high initial response rates, with many patients showing significant reduction or complete disappearance of tumors.
4. Survivorship: Many lymphoma survivors go on to lead healthy, fulfilling lives. Long-term follow-up studies show that most individuals achieve a normal or near-normal quality of life after treatment, especially with supportive care and monitoring.

Treatment Modalities

• Combination Chemotherapy: Most lymphomas are treated with combination chemotherapy, which enhances the effectiveness of treatment and reduces the risk of resistance. Such regimens have improved overall survival rates for various lymphoma types.
• Radiation Therapy: For localized lymphoma, radiation therapy can be highly effective. It often leads to excellent outcomes, especially in early-stage Hodgkin lymphoma, with success rates over 90%.
• Stem Cell Transplants: For patients with relapsed or refractory lymphoma, autologous stem cell transplants can offer a chance of long-term remission. Survival rates post-transplant can be around 50-60%, depending on various factors.

Ongoing Research and Future Prospects

Customized Treatment Approaches: Advances in genetics and molecular biology allow for more personalized treatment approaches, enabling physicians to tailor therapies based on individual patient characteristics and disease profiles.

How is Lung Cancer Diagnosed?

The path to effective treatment begins with an accurate diagnosis of lung cancer. Understanding the tests involved in determining lung cancer type, stage, and whether the disease has spread to other areas of the body is essential.

Lung Cancer Detection and Diagnosis

Early detection is key to successfully treating lung cancer. This is why it is critical for smokers and former smokers to have annual lung screenings, as symptoms often do not manifest until the cancer has reached an advanced stage.

Tests Used for Lung Cancer Diagnosis

A variety of tests help in detecting, diagnosing, and staging lung cancer, as well as in understanding whether the cancer has metastasized to other parts of the body. A biopsy remains the most definitive method for diagnosis, involving the collection of a small tissue sample for laboratory testing. Your doctor will consider several factors when selecting the appropriate diagnostic tests, including the size and location of the suspected cancer, your symptoms, overall health, and prior test results.

Common diagnostic tests include:

• Chest X-ray:Provides images of the organs and bones in the chest.
• CT Scan:Offers detailed cross-sectional images of the chest, abdomen, and brain, often with a contrast dye.
• MRI:Utilizes magnets and radio waves to create detailed images of internal structures.
• PET Scan:Detects malignant cells by using radioactive glucose, highlighting areas of increased activity.
• Radionuclide Bone Scan:Identifies cancer cells in the bones through a small injection of radioactive material.

Specific Diagnostic Procedures

Procedures to confirm the diagnosis of lung cancer may include:

• Fine-Needle Aspiration (FNA) Biopsy:Targets abnormal lung tissue to collect samples for testing.
• Thoracentesis:Removes fluid to check for cancer cells in the space surrounding the lung.
• Sputum Cytology:An examination of mucus from the lungs for cancer cells.

Molecular Testing for Non-Small Cell Lung Cancer

Genetic testing is critical for understanding mutations within the cancerous tissue that may respond to targeted therapies. Biomarker testing, such as PD-L1 evaluation, can inform immunotherapy options.

If you’ve recently received a lung cancer diagnosis, the EPCC team is here to support you every step of the way. We offer access to advanced treatment options and resources designed for you and your loved ones.

Personalized Lung Cancer Treatment Plans

Each treatment plan is individualized based on the type and stage of lung cancer as well as your overall health. Our lung cancer care team collaborates closely to offer the best protocols and recommend a comprehensive treatment plan tailored specifically for you.

Understanding Your Treatment Options

Having open conversations with your oncologist is crucial. We want to ensure you fully comprehend your lung cancer treatment plan, the expected timeline, and how we will monitor its effectiveness. Our lung cancer specialists at EPCC are committed to helping you feel comfortable and confident in your treatment decisions, working alongside you to develop a plan suited to your unique situation.

Together, we can take meaningful steps toward effectively managing lung cancer and improving your quality of life.

Expert Lung Cancer Treatment, Close to Home

At El Portal Cancer Centers, we understand that a lung cancer diagnosis can be a daunting experience. Fortunately, many treatment options are available, and we are dedicated to tailoring these solutions to meet your individual needs and preferences. Our approach is grounded in the specific type and stage of your lung cancer, ensuring that you receive the most effective care possible.

Chemotherapy for Lung Cancer

Chemotherapy is a cornerstone of cancer treatment that utilizes powerful medications to halt the growth of cancer cells, whether by destroying them or preventing their division. Given that lung cancer often spreads rapidly, chemotherapy plays a critical role in many treatment plans, aimed at eradicating these cells.

The administration of chemotherapy can vary based on your specific situation:

• Systemic Chemotherapy:When the medication is taken orally or injected into a vein or muscle, it enters the bloodstream, reaching cancer cells throughout the body.
• Regional Chemotherapy:If injected directly into the spinal column, an organ, or a body cavity like the abdomen, this method targets cancer cells in those localized areas.

Chemotherapy Approaches for Small Cell Lung Cancer (SCLC)

Chemotherapy often forms an integral part of the treatment for SCLC, administered in various ways:

• Chemoradiation:Combining chemotherapy with radiation therapy is commonly recommended for patients with limited-stage SCLC.
• Primary Treatment:For some patients with advanced SCLC, chemotherapy may serve as the main treatment option.

Chemotherapy for Non-Small Cell Lung Cancer (NSCLC)

For patients with NSCLC, chemotherapy may not always be included in the treatment plan, but it can be appropriate in certain scenarios:

• Before Surgery:Chemotherapy may be utilized to shrink a tumor, paving the way for less extensive surgical intervention.
• After Surgery:To eliminate any remaining cancer cells that may not be visible through imaging technology, chemotherapy may follow surgical procedures.
• For Advanced NSCLC:If the cancer has invaded surrounding areas, chemotherapy combined with radiation can be a critical treatment approach, particularly for tumors that have not yet spread to distant organs.

Radiation Therapy for Lung Cancer

There are two primary types of radiation therapy used in lung cancer treatment:

• External Radiation Therapy:This method employs a machine to direct radiation toward the cancer from outside the body.
• Internal Radiation Therapy:This involves placing a radioactive substance directly into or near the tumor through sealed needles, seeds, or catheters. Prophylactic cranial irradiation may also be utilized to prevent the cancer from spreading to the brain.

External beam radiation therapy (EBRT) is the most common form used in lung cancer treatment. This procedure targets high-energy beams at the tumor from outside your body, allowing for a treatment experience similar to receiving an X-ray.

Typically, patients undergo radiation sessions once or twice a day, five days a week, over a period of five to seven weeks, depending on the specific goals and stage of treatment.

Advanced Technologies in External Beam Radiation Therapy

At El Portal Cancer Centers, we utilize cutting-edge external beam radiation therapies to enhance treatment effectiveness while minimizing damage to surrounding healthy tissue. Our techniques include:

• 3-Dimensional Conformal or Intensity-Modulated Radiation Therapy (IMRT):This advanced system uses specialized equipment to break radiation beams into smaller, adjustable segments, ensuring a precise delivery aimed directly at the tumor while sparing healthy areas.
• Stereotactic Body Radiation Therapy (SBRT):Using advanced imaging techniques, SBRT targets lung tumors with pinpoint accuracy, delivering high doses of radiation in just one to five treatments, ideal for patients who cannot undergo surgery.

Surgery for Lung Cancer

Small Cell Lung Cancer Surgery

Although less common, surgical options may be considered for small cell lung cancer in select cases where the cancer is localized to one lung and nearby lymph nodes. However, due to the nature of SCLC’s rapid spread, surgical intervention is less frequently utilized.

Non-Small Cell Lung Cancer Surgery

Patients diagnosed with early-stage NSCLC are more likely to undergo surgery to remove tumors. As the cancer advances, surgical options may become more complex due to the potential spread throughout the lung(s).

Post-Surgery Considerations

Even if all visible cancer is removed during surgery, your oncologist may recommend chemotherapy or radiation therapy afterward to target any remaining cancer cells. This follow-up treatment is referred to as adjuvant therapy and is essential for reducing the risk of recurrence.

Lung Cancer Treatments by Stage

Understanding your treatment options based on your lung cancer stage is vital. The approach differs significantly between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). 

Non-Small Cell Lung Cancer: Tailored Treatments by Stage

Understanding the stages of non-small cell lung cancer (NSCLC) is crucial for determining the most effective treatment approach. Each stage presents unique characteristics that guide treatment decisions.

• Stage 0 In Stage 0, cancer cells are present on the lining of the airway but have not yet invaded the lung tissue. This early stage is highly treatable, often requiring surgery alone to remove the affected tissue. Additionally, laser therapy may be employed to destroy these cancer cells.
• Stage 1 Stage 1 NSCLC indicates that the cancer has been detected very early, potentially through a lung cancer screening test. Surgical intervention is typically performed to remove the nodule(s). Following surgery, the removed cells undergo testing to determine whether chemotherapy or immunotherapy is needed based on the specific characteristics of the cancer.
• Stage 2 For patients in Stage 2, surgery is generally recommended to excise the tumor, followed by chemotherapy to eliminate any remaining cancer cells. Depending on the individual case, immunotherapy and targeted drug therapy may also be introduced during this stage, particularly for patients with certain EGFR gene mutations.
• Stage 3 At Stage 3, surgical options may still be considered; however, the presence of multiple nodules throughout the lungs can complicate effective surgical intervention. In these cases, alternative treatments such as chemotherapy, radiation therapy, immunotherapy, or targeted therapies may serve as first-line options to manage the disease.
• Stage 4A In Stage 4, cancer has spread beyond the lungs to another part of the body, such as the brain. However, if the cancer has only metastasized to one additional area, surgery may still be an option to remove the tumor from that location. Radiation therapy may also be utilized to address and destroy any remaining cancer cells.
• Stage 4B Stage 4B indicates that cancer has often disseminated throughout the body or to various sites. In such cases, biomarker testing becomes a valuable tool to identify specific genetic mutations, guiding the use of targeted therapies aimed at halting cancer growth.

What is Gynecologic Cancer?

Gynecologic cancer refers to cancers affecting the female reproductive system. The five primary types include ovarian, cervical, endometrial, vulvar, and vaginal cancers. Each type presents distinct characteristics, yet early detection remains critical for effective treatment.

Types of Gynecologic Cancers

The six primary types of gynecologic cancers include:

1. Cervical:Originates in the cervix, the lower end of the uterus leading to the vagina.
2. Ovarian:Begins in the ovaries, the female reproductive glands located on either side of the uterus.
3. Uterine (Endometrial):Arises in the uterus, the organ where fetal development occurs.
4. Vaginal:Develops in the vagina, the channel between the uterus and the outside of the body.
5. Vulvar:Occurs on the vulva, the external part of the female genitalia.
6. Tubal:Begins in the fallopian tubes.

While treatment options will vary according to cancer type, tumor grade, and cancer stage, surgery is nearly always a crucial component. Many treatment plans also include chemotherapy and/or radiation therapy. At El Portal Cancer Centers, our team works collaboratively—our surgeon, medical oncologists, and radiation oncologists join forces to ensure you receive the most comprehensive and integrated care possible.

What are the Risk Factors?

All women face a risk of developing gynecologic cancers, and this risk increases with age. While some risk factors are controllable, others are not.

Commonly associated controllable risk factors include:

• Human papillomavirus (HPV) infection
• Long-term oral contraceptive use
• Being overweight or obese
• Poor nutrition
• Smoking
• Exposure to diethylstilbestrol (DES)
• Human immunodeficiency virus (HIV/AIDS) infection

In addition to making lifestyle changes—such as maintaining a balanced diet and exercising regularly—discussing your concerns with your doctor can lead to proactive measures for risk reduction, like the HPV vaccine.

Unfortunately, some risk factors are beyond your control, including age, race, and family history. It’s essential to remember that many women with risk factors never develop gynecologic cancer. If there is a family history of certain cancers, consider discussing genetic testing options with your healthcare provider.

What Symptoms Should I Watch For?

Being aware of potential symptoms can help facilitate early detection. Some symptoms include:

• Abnormal vaginal bleeding or discharge
• Pelvic pain
• Pain during intercourse
• Frequent or urgent bowel changes
• Bloating or a feeling of fullness

If you experience any of these symptoms for more than a month, we strongly recommend scheduling an appointment with your gynecologist. Regular check-ups are vital, even in the absence of symptoms.

What Should I Ask My Doctor?

Establishing an open dialogue with your doctor is crucial for understanding gynecologic cancer. Consider asking:

• What is a Pap test, and why is it necessary?
• How often should I schedule Pap tests?
• What do my Pap results mean?
• Is an HPV test appropriate for me?
• When can I discontinue Pap testing?

How are Gynecologic Cancers Treated? A treatment plan for gynecologic cancers is tailored to each individual. Surgery is generally the first step, often followed by a combination of chemotherapy and/or radiation therapy. Our specialists collaborate closely to ensure every aspect of your treatment is addressed thoroughly.

Are All Gynecologic Conditions Cancerous? Not all gynecological conditions are cancerous. Many benign conditions may resolve on their own or can be treated effectively. Examples include fibroids, ovarian cysts, and pelvic infections, each of which may require specific management based on severity.

Robotic-Assisted Surgery and Gynecologic Care

At El Portal Cancer Centers, we offer robotic-assisted surgery, a minimally invasive option that reduces recovery time and minimizes surgical trauma. This advanced approach allows for precise procedures through smaller incisions, resulting in less pain and scarring, lower infection risks, and quicker returns to daily activities.

Minimally Invasive Surgery Options

• Laparoscopic Surgery:A gold standard in gynecologic procedures, this technique involves small incisions and utilizes a camera to guide the surgeon.\
• Robotic-Assisted Surgery: A New Era in Gynecologic CareThe landscape of gynecologic surgery has transformed significantly. At El Portal Cancer Centers (EPCC), we are proud to offer robotic-assisted surgery, a forward-thinking option that allows for minimally invasive procedures with enhanced precision and improved outcomes. This advanced technique utilizes specialized robotic instruments coupled with a unique 3D high-definition view of the surgical site, empowering your surgeon to perform with remarkable accuracy.

Advance Care Planning (ACP) is an ongoing process that helps you understand your healthcare options and express your preferences. It empowers you to have a say in your future medical care and provides guidance for your medical team should you become unable to communicate. Making these decisions now allows you and your loved ones to focus on quality of life and peace of mind.

Our compassionate counselors will guide you through a thoughtful process to clarify your values, goals, and wishes for care. This includes:

• Reflecting on what matters most to you for a good quality of life
• Learning about different treatment options and how to communicate your goals
• Discussing life-sustaining treatments and your feelings about them
• Choosing a Healthcare Proxy or Surrogate—someone you trust to speak for you
• Putting your wishes into writing through legal documentation
• Exploring your personal values and care goals

Before meeting with an EPCC social worker, it’s helpful to reflect on your values and wishes. Consider questions like:

• What is your understanding of your illness?
• How much do you want to know about your health, and how would you like to receive information?
• What fears or worries do you have?
• Who supports you, and how much do they know about your wishes?
• If you haven’t named a decision maker, who would step in if you’re unconscious or confused?
• What brings you joy and contributes to your quality of life?
• What are your goals for the coming months?

You may also want to think about areas such as:

• Independence and activity level
• Nutrition and sleep
• Sexuality and intimacy
• Spirituality and faith
• Pain management
• Communication with your healthcare team
• Relationships with loved ones
• End-of-life preferences

Why Is This Important?

Even if your health is currently good, discussing your wishes is essential. It ensures your loved ones and healthcare providers understand your values and preferences, preventing unnecessary distress during difficult times. Ongoing conversations and documented wishes serve both as a meaningful gift and a protective measure for you and those you care about.

Reflect on these questions to further inform your plan:

• What would your approach be if you became too weak to get out of bed?
• If at the end of life, you couldn’t improve, would you want life-sustaining machines or prefer comfort and natural death? Are there treatments you would refuse?
• Where would you prefer to receive end-of-life care—at home, in the hospital, or elsewhere?

Your Care Team Supports You

Advance care planning is a standard and important part of your treatment journey, even if your cancer is highly treatable. Knowing that your care team is aware of your wishes offers peace of mind, and it takes the burden off your loved ones during challenging times.

Remember, discussing and documenting your wishes is a caring act—one that respects your dignity and ensures your voice is heard, now and in the future.

During Treatment

Receiving a cancer diagnosis can evoke feelings of shock, fear, anger, or uncertainty. The stress of treatment side effects, hospital visits, and lifestyle changes can lead to anxiety and depression. It is normal to experience a wide range of emotions during this time. Maintaining open communication with your healthcare team about your emotional well-being is essential. Psychological support or counseling can provide tools to manage anxiety, depressive symptoms, and emotional distress.

Surviving Cancer

While completing treatment brings relief, many survivors face ongoing emotional challenges such as fear of recurrence, adapting to physical changes, or reintegrating into daily life. Feelings of vulnerability, grief, or identity shifts are common. Building a support network, engaging in self-care, and participating in survivorship programs can foster resilience and emotional strength. Remember, healing is not only physical but also mental and emotional.

Supporting mental health throughout the cancer journey involves accessing appropriate resources:

• Counseling and Therapy: Licensed mental health professionals, including psychologists and social workers, specialize in addressing cancer-related emotional issues. Sessions can offer coping strategies, emotional processing, and support for anxiety or depression.
• Support Groups: Connecting with others who have similar experiences provides comfort, shared knowledge, and a sense of community. Many organizations offer in-person and virtual support groups for patients and caregivers.
• Mind-Body Techniques: Practices such as meditation, yoga, relaxation exercises, or journaling can reduce stress and promote emotional balance.
• Educational Resources: Learning about common emotional reactions to cancer can normalize your experience and provide helpful coping tips. Many cancer centers and organizations offer educational materials or workshops.
• Emergency Support: If you experience severe depression, thoughts of self-harm, or suicidal feelings, seek immediate help by contacting emergency services or going to the nearest emergency room.

Where to Get Help:

• Talk to your healthcare team about mental health concerns; they can refer you to mental health specialists experienced in oncology.
• Contact local mental health clinics or community organizations offering counseling services.
• Utilize national resources like the American Cancer Society’s Reach To Recovery program or the National Alliance on Mental Illness (NAMI).

Most colorectal cancers are detected during routine screenings, which have become more streamlined, making it easier for you to stay on track with your health. It’s essential to know the types of tests available for early detection of colorectal cancer.

1. Colonoscopy: This procedure involves using a long, flexible tube with a camera to examine the entire colon and rectum. It’s the most comprehensive screening method and allows for the removal of polyps during the exam.
2. Flexible Sigmoidoscopy: Similar to a colonoscopy but examines only the rectum and the lower part of the colon. It requires less preparation and can be done in a doctor’s office.
3. Fecal Occult Blood Test (FOBT): This non-invasive test checks for hidden blood in the stool, which can be a sign of cancer or polyps. It usually requires multiple stool samples over several days.
4. Fecal Immunochemical Test (FIT): Another stool test that detects blood in the stool using antibodies. It’s more specific than the FOBT and does not require dietary restrictions.
5. CT Colonography (Virtual Colonoscopy): This imaging test uses X-rays and computer technology to create detailed pictures of the colon. It’s less invasive than a traditional colonoscopy but cannot remove polyps.
6. DNA Stool Test: This test analyzes stool samples for specific DNA markers that may indicate the presence of cancer or pre-cancerous conditions. It can be more comprehensive in its approach.
7. Blood Tests: While not used for routine screening, certain blood tests may help assess liver function or detect tumor markers in some cases.

These tests help identify colorectal cancer or pre-cancerous polyps early when treatment is most effective. It’s important to discuss with a healthcare provider which screening method is best suited for individual risk factors and medical history.

Plainly put: Regular screening can save lives!

During the early stages of colorectal cancer, there are typically no visible signs of its presence, making screenings crucial for identifying pre-cancerous and cancerous areas while they are still small. Early detection often leads to fewer treatment demands and greatly increases success rates.

Although it might feel uncomfortable, please don’t shy away from scheduling your screening, especially if you are over 40. Taking this step with your primary care physician can help you create a personalized colon cancer screening plan that is right for you.

Several screening tests are available, ranging from convenient at-home options to more comprehensive procedures performed at healthcare facilities. Your doctor will work with you to select the best method based on your age and family history.

At-Home Screening Options

These tests allow you to screen in the comfort of your home without extensive preparation, though they may carry risks of false positives.

1. At-Home Testing for Colorectal Cancer: If you are under 50, your physician may recommend at-home testing before scheduling a colonoscopy. This approach lets you complete the test without a day of prior colon preparation. However, it’s essential to note that these tests may overlook some polyps and cancers.
2. Stool DNA Test: Advances in at-home stool testing, such as Cologuard, have made it easier to conduct Fecal Immunochemical Tests (FIT). This simple test checks for blood and genetic changes without requiring extensive dietary changes.
3. Guaiac-based Fecal Occult Blood Test (gFBOT): Another home test prescribed by your doctor, gFBOT identifies hidden blood in the stool. If blood is detected, follow-up with a colonoscopy is typically necessary.

Screening at Healthcare Facilities

Screening procedures conducted in medical facilities are often the most accurate and valuable in colorectal cancer detection, allowing for the immediate removal of any suspicious polyps.

• Standard Colonoscopy: In this procedure, a colonoscope provides detailed images of your colon and allows for tissue removal if abnormalities are found. Proper preparation and sedation are necessary for successful outcomes, and studies show that regular colonoscopies can significantly reduce colorectal cancer mortality rates.
• Virtual Colonoscopy: Utilizing CT imaging to view your colon, this test usually does not require sedation but does involve bowel preparation. If potential issues arise, a standard colonoscopy may follow for confirmation.

When Should You Be Screened for Colorectal Cancer?

The American Cancer Society (ACS) has recently lowered the recommended screening age from 50 to 45 due to rising colorectal cancer rates among younger adults. Contributing factors may include dietary choices, physical inactivity, and obesity.
Recommended screening frequencies vary based on risk levels:

• Average Risk: Adults with no family history of colorectal cancer should undergo screenings every ten years.
• High Risk: Those with a family history, previous inflammatory diseases, or prior radiation exposure to the pelvic area should start screenings earlier and have them more frequently.

Like many cancers, various factors influence your risk of developing colorectal cancer—some of which are controllable and others that are not. While no one can predict with certainty if or when colorectal cancer will arise, educating yourself about these risk factors can empower you to take proactive measures to reduce your likelihood of diagnosis.

By staying informed and proactive, you can play an essential role in your health journey and work towards minimizing your risk of colorectal cancer. At El Portal Comprehensive Cancer Centers, we are here to support you with expertise and compassion every step of the way.

As you process this life-changing news, know that El Portal Cancer Centers and our staff stand with you, offering strength and compassionate encouragement as you navigate treatment and beyond. You can count on us to help you regain control and move forward with hope and resilience. Together, we are dedicated to supporting you through every phase of your cancer journey.

After a breast cancer diagnosis, here are several important steps to follow to ensure comprehensive care and support. This outline will help you to navigate what happens next.

1. Consultation: Meet with your oncologist and other specialists to discuss the diagnosis, staging of the cancer, and available treatment options. This may include surgical options, radiation therapy, chemotherapy, targeted therapy, or hormone therapy.

2. Treatment Planning: Work with your medical team to develop a personalized treatment plan based on the type of breast cancer, its stage, and your overall health. This plan should outline the proposed treatments, timelines, and potential side effects.

3. Second Opinion: Consider seeking a second opinion from another healthcare professional or cancer center. This can provide additional perspectives on your treatment options and help you feel more confident in your decisions.

4. Learn About Your Diagnosis: Educate yourself about your specific type of breast cancer, treatment options, and potential side effects. Understanding your condition can empower you to make informed decisions.

5. Emotional Support: Reach out for emotional support from family, friends, or support groups. Talking with others who have gone through similar experiences can help you cope with the emotional challenges of a cancer diagnosis.

6. Nutrition and Wellness: Focus on maintaining a healthy diet and lifestyle. A nutritionist may help you develop a meal plan that supports your treatment and overall health. Incorporating physical activity, if possible, can also be beneficial.

7. Regular Monitoring and Follow-Up: Schedule regular follow-up appointments with your healthcare team to monitor your progress and manage any side effects of treatment. Follow-up care is important for detecting any potential recurrence of cancer.

8. Explore Support Services: Many hospitals and cancer centers offer resources such as counseling, financial assistance, and educational programs. Explore these services to help navigate your journey.

9. Consider Long-Term Planning: Discuss potential long-term effects of treatment with your doctor, including hormonal changes, fertility issues, and menopause. Planning for these aspects can help you prepare emotionally and physically.

10. Celebrate Milestones: Acknowledge and celebrate milestones along your journey, whether it’s completing treatment, receiving positive test results, or simply reaching personal goals.

Every person’s journey is unique, and it’s essential to communicate openly with your healthcare team and loved ones throughout the process. Prioritize self-care, seek support, and remember that it’s okay to ask for help when needed.

El Portal Cancer Centers believe in a team solution customize for each patient with the primary ingredient being compassion.

Receiving a breast cancer diagnosis can feel overwhelming, filled with many appointments and decisions. It is important to remember that you are not alone. At El Portal Cancer Centers, we provide valuable resources and support to help you navigate this journey.

As you process this life-changing news, know that we stand by you, offering strength and encouragement as you navigate treatment and beyond. You can count on us to help you regain control and move forward with hope and resilience. Together, we are dedicated to supporting you through every phase of your cancer journey.

There are several methods for checking and detecting breast cancer. Here are some commonly recommended strategies:

1. Breast Self-Examination (BSE): Women can perform self-exams to familiarize themselves with the normal look and feel of their breasts. This involves checking for any unusual lumps, changes in shape, texture, or size, and reporting any concerns to a healthcare provider.

2. Clinical Breast Examination (CBE): A healthcare provider performs a physical examination of the breasts during a routine check-up. They look for any abnormalities, lumps, or changes and can provide guidance on what to watch for.

3. Mammography: This is an X-ray of the breast, and it is the most effective screening tool for early detection of breast cancer. The American Cancer Society recommends that women begin annual mammograms at age 40 or earlier, depending on individual risk factors.

4. Breast Ultrasound: This imaging test uses sound waves to create pictures of the breast tissue. It’s often used as a supplement to mammography, particularly for women with dense breast tissue or when there are abnormalities found.

5. Magnetic Resonance Imaging (MRI): Breast MRI may be used in certain high-risk individuals or to further investigate abnormalities detected during mammography or ultrasound.

6. Genetic Testing: For individuals with a strong family history of breast cancer, genetic tests (such as BRCA1 and BRCA2) can help determine susceptibility and the need for enhanced screening or preventive measures.

7. Biopsy: If a lump or abnormality is detected, a biopsy may be performed to remove a sample of breast tissue for laboratory analysis to confirm the presence of cancer cells.

Regular screening and monitoring are essential for early detection and improved treatment outcomes. Women should discuss their personal risk factors and screening plans with their healthcare providers to determine the best approach for their individual needs.

Side effects of hormone therapy can vary between men and women due to physiological differences. They may include:

• For Women (Breast Cancer Treatment): Hot flashes, vaginal dryness, mood swings, fatigue, and risk of osteoporosis.
• For Men (Prostate Cancer Treatment): Hot flashes, reduced libido, weight gain, fatigue, and risk of osteoporosis.

While hormone therapy can be a powerful tool against cancer, it’s important to understand potential risks:

• Bone Health:Long-term hormone therapy may affect bone density, leading to increased risk of fractures.
• Cardiovascular Health:Hormonal changes can impact heart health, especially in prolonged use.
• Mood and Cognitive Effects:Hormonal alterations may lead to mood swings or changes in cognitive function.
• Metabolic Changes:There may be a risk of weight gain or changes in metabolism, affecting energy levels.

Hormone therapy offers a vital route to managing and treating certain cancers, personalized to each patient’s needs and circumstances. Patients are encouraged to maintain open communication with their healthcare providers, ensuring that they fully understand the benefits and possible impacts of treatment. With comprehensive care and support, hormone therapy can contribute positively to a patient’s cancer journey.

A cancer diagnosis can profoundly impact family dynamics, routines, and relationships. Family members may experience their own emotional stresses, worry about the patient’s health, and take on new caregiving roles. Communication can become more open or strained, and adjusting to changes in roles—such as caregiver, supporter, or decision-maker—requires flexibility and understanding. Supporting the emotional needs of each family member and seeking family counseling or support groups can help the entire family navigate this challenging time together.

Returning to work after cancer treatment often requires adjustments to accommodate ongoing health needs, fatigue, or emotional changes. Many survivors find they need to modify their schedules, work part-time, or explore flexible work arrangements. Open communication with employers about your needs can foster understanding and support. Establishing a new routine that balances recovery with professional responsibilities helps rebuild confidence and maintain a sense of purpose.

Psychological resilience plays a crucial role in survivorship. Many survivors face emotional challenges such as anxiety, depression, or fear of recurrence. Prioritizing mental health through counseling, support groups, mindfulness practices, or relaxation techniques can foster emotional well-being. Recognizing that emotional healing is part of the journey encourages survivors to seek help when needed and to nurture a positive outlook.

Diagnosing Multiple Myeloma typically involves several steps:

1. Medical History and Physical Examination:
   • Your healthcare provider will start by reviewing your medical history, discussing symptoms you’ve experienced, and conducting a thorough physical examination to check for signs of the disease, such as bone tenderness or swelling.
2. Blood Tests:
   • Blood tests are essential in diagnosing Multiple Myeloma. Common tests include:
     • Complete Blood Count (CBC): Monitors levels of red blood cells, white blood cells, and platelets.
     • Blood Chemistry Tests: Assess kidney function and other vital parameters.
     • Serum Protein Electrophoresis (SPEP): Identifies abnormal proteins (monoclonal proteins) produced by myeloma cells.
     • Free Light Chain Assay: Measures the levels of free light chains in the blood and can indicate the presence of myeloma.

3. Urine Tests:
   • A 24-hour urine collection may be performed to check for Bence Jones protein, a type of light chain protein released by myeloma cells.
4. Bone Marrow Biopsy:
   • A definitive diagnosis often requires a bone marrow biopsy, where a small amount of bone marrow (usually from the hipbone) is extracted and analyzed for abnormal plasma cells.
5. Imaging Tests:
   • Imaging techniques such as X-rays, CT scans, or MRIs are used to assess bone damage or lesions caused by myeloma. These tests help identify areas of bone weakening or fractures.

While the exact cause of Multiple Myeloma remains unknown, several factors may increase the risk:

1. Age: The risk of developing Multiple Myeloma increases with age, most commonly affecting individuals over 65.
2. Gender: Men are more likely to develop Multiple Myeloma than women.
3. Race: African Americans have a higher incidence of Multiple Myeloma compared to Caucasian populations.
4. Family History: A family history of Multiple Myeloma or related plasma cell disorders may increase individual risk.
5. Certain Medical Conditions: Conditions such as monoclonal gammopathy of undetermined significance (MGUS) or other blood disorders can predispose individuals to myeloma.
6. Exposure to Chemicals: Long-term exposure to certain chemicals, such as benzene, and agricultural chemicals, may contribute to the development of myeloma.

Recognizing the signs and symptoms of Multiple Myeloma is crucial for early intervention:

1. Bone Pain: Persistent pain, particularly in the back, hips, or ribs, may indicate damage to the bones caused by myeloma lesions.
2. Fatigue: Anemia, caused by reduced red blood cell production, often leads to fatigue and weakness.
3. Frequent Infections: Compromised immune function due to myeloma can make patients more susceptible to infections.
4. Unexplained Weight Loss: Patients may experience unexplained weight loss with no changes in their regular diet or physical activity.

Treatment for Multiple Myeloma is generally tailored to individual patient needs and the disease’s specific characteristics. Here are the primary treatment options:

1. Chemotherapy: Chemotherapy remains a cornerstone of treatment for Multiple Myeloma. Regimens may include combinations such as:
   • Bortezomib (Velcade):A proteasome inhibitor that blocks protein degradation pathways in cancer cells.
   • Dexamethasone:A corticosteroid used in combination with other drugs to reduce inflammation and manage symptoms.
   • Lenalidomide (Revlimid):An immunomodulatory drug that enhances the immune response against myeloma cells.
2. Targeted Therapy: Targeted therapies focus specifically on cancerous cells, minimizing harm to normal cells:
   • Monoclonal Antibodies:Medications like daratumumab (Darzalex) are designed to target specific proteins on myeloma cells, leading to their destruction.
   • Carfilzomib (Kyprolis):A newer proteasome inhibitor used in patients with relapsed or refractory myeloma.
3. Immunotherapy: Immunotherapies use the body’s immune system to fight cancer:
   • Chimeric Antigen Receptor (CAR) T-Cell Therapy:This innovative approach involves modifying a patient’s T-cells to better recognize and attack myeloma cells. It has shown promise for some patients with difficult-to-treat myeloma.
4. Stem Cell Transplant: For eligible patients, stem cell transplant can provide an opportunity for long-term remission:
   • Autologous Stem Cell Transplant:This involves harvesting the patient’s own stem cells, administering high-dose chemotherapy to eliminate cancer cells, and then reinfusing the healthy stem cells.
5. Radiation Therapy: Radiation can be used to relieve pain or target specific areas affected by multiple myeloma, particularly in cases of localized disease or bone lesions.
6. Supportive Care: Supportive care plays a vital role in managing symptoms and improving quality of life. This may include medications for pain relief, management of anemia, hydration support, and nutritional counseling.

Difficulty Sleeping – Sleep disturbances can occur during treatment, which may exacerbate fatigue. Consider these strategies to improve sleep:

• Create a calming bedtime routine.
• Keep your sleeping environment dark, cool, and quiet.
• Go to bed and wake up at consistent times.
• Limit screen time before bed and reduce caffeine intake.
• Discuss melatonin or other sleep aids with your healthcare provider.

Fatigue – Fatigue can be overwhelming and may affect your mental health as well. Strategies for managing fatigue include:

• Engaging in regular, light exercise to boost energy levels.
• Practicing yoga or meditation to alleviate emotional stresses.
• Consulting with a counselor or social worker for additional support.

Hair Loss – While hair loss is often associated with cancer treatment, not every patient will experience it. To manage hair loss:

• Be gentle with your hair care routine and consider head coverings or wigs to boost your confidence.
• Use cooling caps, if recommended, to possibly reduce hair loss during chemotherapy.
• Connect with support groups to share experiences and feelings surrounding hair loss.

Skin Problems – Treatments can lead to various skin changes. To care for your skin during treatment:

• Keep affected areas clean and moisturized with gentle, fragrance-free products.
• Wear loose-fitting clothing and use sunscreen to protect sensitive skin.

Loss of Appetite – Maintaining proper nutrition is vital during treatment. If you experience appetite changes:

• Opt for smaller, more frequent meals packed with protein.
• Stay hydrated and ask about anti-nausea medications that can improve your eating experience.
• Consider discussing dietary changes with a nutritionist.

Nausea and Vomiting – These are common effects of many cancer treatments. To mitigate nausea:

• Avoid strong scents and stick to bland foods.
• Maintain hydration, especially with electrolyte drinks if vomiting occurs.
• Take prescribed anti-nausea medications as directed.

Lymphedema – This condition may result from surgery or radiation impacting the lymphatic system. To manage lymphedema:

• Wear compression garments and consult with a certified lymphedema therapist for specialized care.
• Regular exercise and gentle stretching can improve lymph fluid drainage.

Pain – Managing pain effectively is crucial to your overall well-being. Strategies include:

• Taking prescribed medications consistently and discussing pain management options with your doctor.
• Applying heat or ice to areas of discomfort, depending on what provides relief.